Page 1 of Clinical Trials for Other immunoenzyme technique, 149 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Sunitinib in Treating Patients With Unresectable or Metastatic Kidney Cancer or Other Advanced Solid Tumors
Last Updated: October 8, 2010
Condition(s): Kidney Cancer; Unspecified Adult Solid Tumor, Protocol Specific
2
Completed
Studying Cells Collected Through Ductal Lavage in Women Undergoing Surgery for Ductal Carcinoma In Situ or Other Breast Cancer
Last Updated: November 20, 2009
Condition(s): Breast Cancer
3
Recruiting
Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other Disease
Last Updated: November 4, 2011
Condition(s): Graft Versus Host Disease; Infection; Leukemia; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
4
Completed
Bortezomib and Pemetrexed Disodium in Treating Patients With Advanced Non-Small Cell Lung Cancer or Other Solid Tumors
Last Updated: February 6, 2009
Condition(s): Lung Cancer; Unspecified Adult Solid Tumor, Protocol Specific
5
Recruiting
Temozolomide in Treating Patients With Recurrent Glioblastoma Multiforme or Other Malignant Glioma
Last Updated: January 22, 2011
Condition(s): Brain and Central Nervous System Tumors
6
Active, not recruiting
DNA Changes as a Risk Factor for Barrett's Esophagus in Patients With Barrett's Esophagus, Gastroesophageal Reflux, or Gastrointestinal Bleeding
Last Updated: February 1, 2010
Condition(s): Precancerous Condition
7
Recruiting
Vorinostat, Cisplatin, and Radiation Therapy in Treating Patients With Stage III or Stage IV Squamous Cell Cancer of the Oropharynx
Last Updated: November 17, 2011
Condition(s): Stage III Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx
8
Recruiting
TLR8 Agonist VTX-2337 and Cetuximab in Treating Patients With Locally Advanced, Recurrent, or Metastatic Squamous Cell Cancer of Head and Neck
Last Updated: January 12, 2012
Condition(s): Metastatic Squamous Neck Cancer With Occult Primary Squamous Cell Carcinoma; Recurrent Metastatic Squamous Neck Cancer With Occult Primary; Recurrent Salivary Gland Cancer; Recurrent Squamous Cell Carcinoma of the Hypopharynx; Recurrent Squamous Cell Carcinoma of the Larynx; Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity; Recurrent Squamous Cell Carcinoma of the Nasopharynx; Recurrent Squamous Cell Carcinoma of the Oropharynx; Recurrent Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Recurrent Verrucous Carcinoma of the Larynx; Recurrent Verrucous Carcinoma of the Oral Cavity; Salivary Gland Squamous Cell Carcinoma; Stage III Salivary Gland Cancer; Stage III Squamous Cell Carcinoma of the Hypopharynx; Stage III Squamous Cell Carcinoma of the Larynx; Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage III Squamous Cell Carcinoma of the Nasopharynx; Stage III Squamous Cell Carcinoma of the Oropharynx; Stage III Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage III Verrucous Carcinoma of the Larynx; Stage III Verrucous Carcinoma of the Oral Cavity; Stage IV Salivary Gland Cancer; Stage IV Squamous Cell Carcinoma of the Hypopharynx; Stage IV Squamous Cell Carcinoma of the Larynx; Stage IV Squamous Cell Carcinoma of the Lip and Oral Cavity; Stage IV Squamous Cell Carcinoma of the Nasopharynx; Stage IV Squamous Cell Carcinoma of the Oropharynx; Stage IV Squamous Cell Carcinoma of the Paranasal Sinus and Nasal Cavity; Stage IV Verrucous Carcinoma of the Larynx; Stage IV Verrucous Carcinoma of the Oral Cavity; Tongue Cancer
9
Recruiting
Laboratory-Treated T Cells and Ipilimumab in Treating Patients With Metastatic Melanoma
Last Updated: February 3, 2012
Condition(s): Recurrent Melanoma; Stage IV Melanoma
10
Suspended
Bevacizumab and Sorafenib in Treating Patients With Recurrent Glioblastoma Multiforme
Last Updated: July 20, 2010
Condition(s): Brain and Central Nervous System Tumors
11
Active, not recruiting
Research Study in Healthy Volunteers or Patients With Fanconi Anemia, Myeloproliferative Disorders, or Myeloma
Last Updated: April 16, 2012
Condition(s): Chronic Myeloproliferative Disorders; Fanconi Anemia; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic/Myeloproliferative Neoplasms
12
Recruiting
Exercise Programs in Healthy Young Women at Increased Risk of Developing Breast Cancer
Last Updated: May 8, 2010
Condition(s): Breast Cancer; Healthy, no Evidence of Disease
13
Recruiting
Autoantibody Blood Test in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer
Last Updated: November 7, 2011
Condition(s): Kidney Cancer
14
Completed
SB939 in Treating Patients With Locally Advanced or Metastatic Solid Tumors
Last Updated: June 21, 2011
Condition(s): Unspecified Adult Solid Tumor, Protocol Specific
15
Active, not recruiting
Vaccine Therapy in Treating Patients With Myelodysplastic Syndromes
Last Updated: October 1, 2010
Condition(s): Myelodysplastic Syndromes
16
Active, not recruiting
Floxuridine and Dexamethasone as a Hepatic Arterial Infusion and Bevacizumab in Treating Patients With Primary Liver Cancer That Cannot be Removed by Surgery
Last Updated: October 14, 2010
Condition(s): Liver Cancer
17
Active, not recruiting
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer
Last Updated: March 11, 2009
Condition(s): Breast Cancer
18
Recruiting
Trastuzumab, Cyclophosphamide, and Vaccine Therapy in Treating Patients With High-Risk or Metastatic Breast Cancer
Last Updated: January 27, 2012
Condition(s): Breast Cancer
19
Completed
Bevacizumab and Erlotinib in Treating Patients With Advanced Liver Cancer
Last Updated: November 18, 2011
Condition(s): Liver Cancer
20
Active, not recruiting
Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery
Last Updated: May 21, 2010
Condition(s): Head and Neck Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Other+immunoenzyme+technique

Page 1 of Clinical Trials for Other immunoenzyme technique, 149 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About